The hidden risk: Incorporating inflammation and HIV serostatus into coronary artery disease screening

Academic Article

Abstract

  • CAD is a well-established comorbidity associated with HIV infection. This association is in large part due to ongoing inflammation propagated by viremia and dysregulation of the immune system. Despite this knowledge, evidence to guide clinical management and screening for CAD among HIV-infected patients is lacking. The following editorial discusses recent evidence that HIV-infected patients with abnormal cardiovascular stress testing are more likely to undergo subsequent percutaneous coronary intervention. Importantly, the cardiovascular consequences of HIV infection and potential clinical implications are discussed.
  • Authors

    Published In

    Digital Object Identifier (doi)

    Author List

  • Payne GA; Overton ET
  • Start Page

  • 884
  • End Page

  • 886
  • Volume

  • 25
  • Issue

  • 3